Compositions and methods for detecting anti-endothelial cell antibodies in allograft rejection
Abstract:
Provided herein are methods, compositions, and kits for diagnosing allograft rejection of organ transplants by identifying the presence of anti-endothelial cell antibodies. Such methods and compositions are independent of external confounders such as recipient age, transplant center, assay, cause of end-stage disease, co-morbidities, immunosuppression usage, and the like.
Information query
Patent Agency Ranking
0/0